Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Pancreas. 2012 Jul;41(5):678–684. doi: 10.1097/MPA.0b013e318249955a

Table 2.

Clinicopathologic Details

Histology
Stage
Author Patients Adenocarcinoma Other Unknown1 Stage I/II Stage III Stage IV Unknown1 Staging System
Fiorentini 20 20 - - - 12 8 - NR
Muchmore 12 11 1 - - - - 12 NR
Link 32 28 4 - - 17 15 - UICC
Lorenz 17 17 - - 2 10 5 - UICC
Maurer 12 12 - - - 6 6 - UICC
Klapdor 28 - - 28 - - 20 8 NR
Homma 31 31 - - - - 31 - UICC
Bayar 14 - - 14 - 5 9 - NR
Ohigashi 32 - - 32 - 32 - - UICC
van Ijken 21 - - 21 - 15 6 - NR
Aigner 265 - - 265 - 112 153 - UICC
Takamori 24 - - 24 - 3 21 - NR
Barletta 32 32 - - - 7 25 - NR
Mambrini 211 203 8 - - 99 112 - UICC
Meyer 17 - - 17 - 7 10 - NR
Guadagni 22 20 2 - - 14 8 - NR
Ikeda 33 19 - 14 - - 33 - NR
Ishikawa 20 - - 20 - - 20 - NR
Milandri 19 17 2 - - 10 9 - NR
Nakchbandi 17 17 - - 2 2 13 - UICC
Sasada 16 9 - 7 - 12 4 - JPS3/TNM
1

Unreported or not confirmed prior to therapy; not discernible from manuscript

2

UICC, International Union Against Cancer

3

Japan Pancreas Society; TNM, tumor, node, metastasis.

NR, not reported.